Loading clinical trials...

Tissue K+ in Primary Hyperaldosteronism | Clinical Trials | Clareo Health

COMPLETEDNCT04251780

Tissue K+ in Primary Hyperaldosteronism

Recent human studies found tissue sodium storage in patients with hyperaldosteronism that could be detected non-invasively by 23Na-MRI. Tissue sodium accumulation could be mobilized upon treatment of ...

Lead sponsor: University of Erlangen-Nürnberg Medical School•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment

NCT05797558 · Primary Hyperaldosteronism Due to Adrenal Adenoma

Enrolling By Invitation

A Prospective Cohort Study for Patients With Adrenal Diseases

NCT03474237 · Adrenal Adenoma, Cushing Syndrome, and more

COMPLETEDPhase 4

5 Versus 10 Units of Insulin in Hyperkalemia Management

NCT06036823 · Hyperkalemia, Potassium Imbalance, and more

COMPLETEDNA

Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producing Adenomas

NCT03405025 · Primary Hyperaldosteronism, Primary Hyperaldosteronism Due to Adrenal Adenoma

COMPLETEDNA

11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism

NCT01567111 · Primary Hyperaldosteronism

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 25, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment21

Start dateJan 2018

Last updatedNov 25, 2025

Condition

Primary Hyperaldosteronism Electrolyte Disturbance

Locations shown

Nephrology Department, University Hospital Erlangen

Erlangen, Bavaria

Radiology Department, University Hospital Erlangen

Erlangen, Bavaria

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 25, 2025Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions